Oral Thin Films Market Trend Analysis And Forecasts to 2027
The global Oral Thin Films market gathered revenue around USD 3.0 Billion in 2020 and market is set to grow USD 5.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.7% during the prediction period 2021 to 2027.
Growth Factors:
The market Oral thin film drug is a promising drug delivery dosage form, which delivers drugs by adhering to the oral mucosa. Rise in demand for thin film drug delivery systems, considerable research & development, and strategic alliances between novel technology owners and large pharmaceutical companies are major factors that are anticipated to drive the global oral thin films market during the forecast period. North America held a major share of the global oral thin films market in 2020, due to higher penetration of the oral thin film technology and increase in focus on new product launches by industry players in the region.
The market Oral thin film drug is a promising drug delivery dosage form, which delivers drugs by adhering to the oral mucosa. Rise in demand for thin film drug delivery systems, considerable research & development, and strategic alliances between novel technology owners and large pharmaceutical companies are major factors that are anticipated to drive the global oral thin films market during the forecast period. North America held a major share of the global oral thin films market in 2020, due to higher penetration of the oral thin film technology and increase in focus on new product launches by industry players in the region.
The oral thin films market in Europe is expected to expand at a high CAGR of 11.1% from 2020 to 2027, due to increase in the number of geriatric patients suffering from dysphagia and rise in oral thin film introductions in the region.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Oral Thin Films market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Oral Thin Films market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
| Report Scope | Details |
| Market Size | USD 5.9 Billion by 2027 |
| Growth Rate | CAGR of 8.7% From 2021 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2027 |
| Historic Data | 2017 to 2020 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | Product type, Component And Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | ZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., LIVKON Pharmaceuticals pvt. Ltd., Shilpa Therapeutics Pvt. Ltd, Sunovion Pharmaceuticals, Inc., NAL Pharma, Cure Pharmaceutical, IntelGenx Corp., Dr. Reddy's Laboratories, Kyu Pharmaceutical Co Ltd, Seoul PharmaCo, and C.L. Pharm. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Oral Thin Films market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Oral Thin Films Market: Key Segments
In terms of product, the global oral thin films market has been classified into sublingual film, fast dissolving oral film, and buccal film
Based on indication, the global oral thin films market has been categorized into pain management, neurological disorders, nausea & vomiting, opioid dependence, and others. The neurological disorders segment dominated the global oral thin films market in 2020, owing to higher incidence rate of neurological disorders, and increase in the prescription of oral thin films for the treatment of schizophrenia and opioid dependence.
In terms of distribution channel, the global oral thin films market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacies segment is expected to expand at a high CAGR from 2020 to 2027. Benefits such as convenience, discounted products, large number of options, and detailed product description offered by online pharmacies are likely to drive the segment during the forecast period.
North America to Dominate Global Market; Europe to Offer Significant Opportunities
In terms of region, the global oral thin films market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for a leading share of the global oral thin films market during the forecast period. Higher penetration of oral thin films, availability of the products, and presence of a large number of suppliers compared to other regions are the major factors driving the market in the region. The market in Asia Pacific is expected to expand at a high CAGR in the near future, owing to the presence of local as well as global players and an increase in the demand for oral thin films in the region. The oral thin films market in Europe is likely to expand at a rapid pace in the near future. Japan and China are anticipated to be lucrative markets for oral thin films during the forecast period. Presence of large geriatric patient population with dysphagia and increase in healthcare expenditure in these countries are projected to propel the market in Asia Pacific over the next few years.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Oral Thin Films Market include: ZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., LIVKON Pharmaceuticals pvt. Ltd., Shilpa Therapeutics Pvt. Ltd, Sunovion Pharmaceuticals, Inc., NAL Pharma, Cure Pharmaceutical, IntelGenx Corp., Dr. Reddy's Laboratories, Kyu Pharmaceutical Co Ltd, Seoul PharmaCo, and C.L. Pharm.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Oral Thin Films Market: Segmentation
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Oral Thin Films market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Oral Thin Films market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Oral Thin Films markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Oral Thin Films market Study:
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers